Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals

Journal of Infectious Diseases

Volumn 185, Issue 12, 2002, Pages 1709-1716

  Kern, Florian ^a   Bunde, Torsten ^a   Faulhaber, Nicole ^a   Kiecker, Felix ^a   Khatamzas, Elham ^a   Rudawski, Ina Maria ^a   Pruss, Axel ^a   Gratama, Jan Willem ^c   Volkmer Engert, Rudolf ^a   Ewert, Ralf ^b   Reinke, Petra ^a   Volk, Hans Dieter ^a   Picker, Louis J ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPITOPE; IMMUNOGLOBULIN G; PEPTIDE; PHOSPHOPROTEIN; PHOSPHOPROTEIN 65; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FLOW CYTOMETRY; HUMAN; MEMORY CELL; MONONUCLEAR CELL; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; SEROLOGY; T LYMPHOCYTE;

AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; EPITOPES, T-LYMPHOCYTE; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; VIRAL MATRIX PROTEINS;

EID: 0037097657     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340637     Document Type: Article

References (34)

1. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
2. Sequence of protein synthesis in cells infected by human cytomegalovirus: Early and late virus-induced polypeptides
3. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T cell receptor usage of pp65-specific CTL
4. Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response
5. Three T cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes
6. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein
7. +T cell clones specifically activated by IE1 peptides in vitro
8. Limiting dilution analysis of helper T cell function
9. Human cytomegalovirus-specific cytotoxic T cells: Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses
10. Phenotypic analysis of antigen-specific T lymphocytes
11. +T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
12. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry
13. T cell epitope mapping by flow cytometry
14. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides
15. +-T-cell response to human cytomegalovirus: The 72-kilodalton major immediate-early protein revisited
16. +memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis
17. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry
18. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo
19. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
20. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients
21. HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections
22. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease
23. Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro
24. Cytotoxic T cells specific for cytomegalovirus: A potential therapy for immunocompromised patients
25. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor
26. Cytomegalovirus reactivation and tumour necrosis factor
27. PCR activity of CMV in healthy CMV-seropositive individuals: Does latency need redefinition?
28. Measurement of anti-human cytomegalovirus T cell reactivity in transplant recipients and its potential clinical use: A mini-review
29. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly
30. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation
31. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression
32. +virus-specific cytotoxic T lymphocytes
33. ++ memory T cell response to cytomegalovirus